Ariad Pharmaceuticals Inc
ARIA
ARIA was delisted on the 15th of February, 2017.
169 hedge funds and large institutions have $655M invested in Ariad Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 24 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 44
4% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 24
0% more funds holding
Funds holding: 169 → 169 (0)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
17% less capital invested
Capital invested by funds: $790M → $655M (-$135M)
23% less call options, than puts
Call options by funds: $20.5M | Put options by funds: $26.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
+$13.6M |
| 2 |
PC
PointState Capital
New York
|
+$10.5M |
| 3 |
DFO
Duquesne Family Office
New York
|
+$9.61M |
| 4 |
O
OppenheimerFunds
New York
|
+$9.46M |
| 5 |
Millennium Management
New York
|
+$8.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$32.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$22M |
| 3 |
Renaissance Technologies
New York
|
-$18.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$12.4M |
ARIA Hedge Fund Activity: Q3 2014 in Review
169 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2014, worth a combined $655M — down 17% from $790M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ARIA positions and 24 closed out — a net gain of 1 holder — while 61 added to existing stakes and 44 trimmed.
The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $13.6M. The largest seller was Franklin Resources, exiting entirely with an estimated $32.1M sold.
- 169 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2014, unchanged from Q2 2014.
- Funds reported $655M of Ariad Pharmaceuticals Inc stock for Q3 2014, down 17% quarter-over-quarter.
- 25 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2014 and 24 closed out, a net change of +1 holder.
- The largest Ariad Pharmaceuticals Inc buyer in Q3 2014 was Columbus Circle Investors, an estimated $13.6M added.
- The largest Ariad Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $32.1M sold.
Based on aggregated 13F filings for Q3 2014.